CRISPR Therapeutics AG (CRSP)
55.08
+2.70
(+5.15%)
USD |
NASDAQ |
May 06, 16:00
54.80
-0.28
(-0.51%)
After-Hours: 20:00
CRISPR Therapeutics EPS Diluted (Quarterly) : -1.280 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.02 |
| Beam Therapeutics, Inc. | 2.328 |
| Novartis AG | 1.654 |
| EvoNext Holdings SA | -- |
| Kuros Biosciences Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -122.93M |
| Revenue (Quarterly) | 1.458M |
| Total Expenses (Quarterly) | 124.39M |
| Enterprise Value | 3.658B |
| Gross Profit Margin (Quarterly) | -3.35K% |
| Profit Margin (Quarterly) | -8.43K% |
| Earnings Yield | -11.28% |
| Normalized Earnings Yield | -9.865 |